IPP Bureau
Morepen Laboratories consolidated Q1 FY26 PAT lower at Rs. 11.40 Cr
By IPP Bureau - August 10, 2025
Morepen Laboratories has reported total income of Rs. 429.64 crores during the period ended June 30, 2025
KIMS Q1 FY26 consolidated profit slips to Rs. 78.6 Cr
By IPP Bureau - August 10, 2025
KIMS has reported total income of Rs. 878.7 crores during the period ended June 30, 2025
Aurobindo Pharma Q1 FY26 PAT slips 10% YoY to Rs. 824 Cr
By IPP Bureau - August 10, 2025
Aurobindo Pharma’s US formulations revenue slipped 1.9% on a year-on-year basis to Rs. 3,488 crore
Zydus receives final approval from USFDA for Prucalopride Tablets
By IPP Bureau - August 09, 2025
Prucalopride is prescribed for chronic idiopathic constipation
Akums reports Q1 FY26 PAT at Rs. 65 Cr
By IPP Bureau - August 09, 2025
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Cupid Q1 FY26 PAT jumps 82% at Rs. 15 Cr
By IPP Bureau - August 09, 2025
Cupid reported total income of Rs. 64.75 crore in Q1 FY26 as compared to Rs. 44.03 crore in Q1 Fy25
Hikal reports Q1 FY26 consolidated loss of Rs. 22.4 Cr
By IPP Bureau - August 08, 2025
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
Sigachi begins construction work for MCC capacity expansion at Dahej
By IPP Bureau - August 08, 2025
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
Metropolis Healthcare reports Q1 FY26 PAT higher by 19% at Rs. 45 Cr
By IPP Bureau - August 08, 2025
ekincare launches elva.AI to resolve 80% of employee healthcare queries
By IPP Bureau - August 08, 2025
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
Quest Diagnostics completes acquisition of Spectra Laboratories’ Clinical Testing Assets from Fresenius Medical Care
By IPP Bureau - August 08, 2025
Quest will now offer dialysis-related clinical testing services to independent dialysis clinics
Primelaze introduces Q-Switched Nd:YAG laser technology in India for skin treatments
By IPP Bureau - August 08, 2025
The Q-Switched Nd:YAG system is suitable for all skin types and offers versatility in treating dermal and epidermal pigmentation
IOL Chemicals post Q1 FY26 consolidated profit at Rs. 33.93 Cr
By IPP Bureau - August 08, 2025
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
Caplin Point Laboratories posts Q1 FY26 consolidated PAT at Rs. 152.80 Cr
By IPP Bureau - August 08, 2025
Caplin Point Laboratories has reported total income of Rs. 533.36 crores during the period ended June 30, 2025















